A SARS-CoV-2 neutralizing antibody discovery by single cell sequencing and molecular modeling

Although vaccines have been developed, mutations of SARS-CoV-2, especially the dominant B.1.617.2 (delta) and B.1.529 (omicron) strains with more than 30 mutations on their spike protein, have caused a significant decline in prophylaxis, calling for the need for drug improvement. Antibodies are drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zheyue, Tang, Qi, Liu, Bende, Zhang, Wenqing, Chen, Yufeng, Ji, Ningfei, Peng, Yan, Yang, Xiaohui, Cui, Daixun, Kong, Weiyu, Tang, Xiaojun, Yang, Tingting, Zhang, Mingshun, Chang, Xinxia, Zhu, Jin, Huang, Mao, Feng, Zhenqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Department of Journal of Biomedical Research 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226085/
https://www.ncbi.nlm.nih.gov/pubmed/36992606
http://dx.doi.org/10.7555/JBR.36.20220221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226085/
https://www.ncbi.nlm.nih.gov/pubmed/36992606
http://dx.doi.org/10.7555/JBR.36.20220221

Ejemplares similares